Vinva Investment Management Ltd Has $6.75 Million Stake in Colgate-Palmolive (NYSE:CL)

Vinva Investment Management Ltd cut its position in Colgate-Palmolive (NYSE:CL - Free Report) by 12.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 74,339 shares of the company's stock after selling 10,365 shares during the period. Vinva Investment Management Ltd's holdings in Colgate-Palmolive were worth $6,749,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. West Tower Group LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $482,000. Enhancing Capital LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at about $364,000. Intech Investment Management LLC raised its stake in shares of Colgate-Palmolive by 312.0% in the fourth quarter. Intech Investment Management LLC now owns 545,551 shares of the company's stock worth $49,596,000 after acquiring an additional 413,134 shares during the last quarter. Generali Asset Management SPA SGR acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $8,105,000. Finally, Mirova US LLC grew its stake in shares of Colgate-Palmolive by 16.3% during the fourth quarter. Mirova US LLC now owns 11,849 shares of the company's stock valued at $1,077,000 after purchasing an additional 1,659 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.0 %

Shares of Colgate-Palmolive stock traded up $0.02 during trading hours on Friday, hitting $90.30. The company's stock had a trading volume of 8,950,637 shares, compared to its average volume of 4,226,202. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The company has a market capitalization of $73.28 billion, a PE ratio of 25.65, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The stock has a 50 day moving average of $89.33 and a 200 day moving average of $94.18.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 earnings per share. Analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a yield of 2.30%. Colgate-Palmolive's dividend payout ratio is presently 56.82%.

Colgate-Palmolive declared that its board has authorized a stock repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.

Analyst Ratings Changes

CL has been the topic of several research reports. Stifel Nicolaus reduced their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a report on Monday, February 3rd. Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating on the stock in a research note on Friday, January 17th. UBS Group lowered their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada restated a "sector perform" rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.